![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (STB)
in HIV-Infected Patients with Mild to Moderate Renal Impairment
|
|
|
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
J Szwarcberg1, JF Andrade-Villanueva2, M Fisher3, J Winston4, Y Liu1, L Zhong1, A Cheng1, MS Rhee1, F Post5
1Gilead Sciences, US; 2Hospital Civil de Guadalajara ÒFray Antonio AlcaldeÓ, Mexico;
3Brighton and Sussex University Hospitals, UK; 4Mount Sinai Hospital, US; 5Kings College Hospital, UK
![IAC1.gif](../images/072814/072814-4/IAC1.gif)
![IAC2.gif](../images/072814/072814-4/IAC2.gif)
![IAC3.gif](../images/072814/072814-4/IAC3.gif)
![IAC4.gif](../images/072814/072814-4/IAC4.gif)
![IAC5.gif](../images/072814/072814-4/IAC5.gif)
![IAC6.gif](../images/072814/072814-4/IAC6.gif)
![IAC7.gif](../images/072814/072814-4/IAC7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|